Viking Therapeutics Inc (NASDAQ:VKTX) traded at $74.31 at close of the session on Friday, April 26, made an upward move of 7.91% on its previous day’s price.
Looking at the stock we see that its previous close was $68.86 . In terms of its 52-week price range, VKTX has a high of $99.41 and a low of $8.28. The company’s stock has lost about -10.84% over that past 30 days.
Viking Therapeutics Inc has a market cap of $8.13 billion. Estimates by analysts give the company expected earnings per share (EPS) of -$0.26, with the EPS growth for the year raised at -$1.1 for 2024 and -$1.54 for next year. These figures represent -20.90% and -40.00% growth in EPS for the two years respectively.
There have been 3 upward and — downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the VKTX stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Looking further, we note the current price level is 4.70% off its SMA20 and 10.47% from its 50-day simple moving average. The RSI (14) is pointing at 58.75 while the volatility over the past week is 7.16% and jumps to 5.84% over the past one month. The beta value is 1.16, while the average true range (ATR) is currently pointing at 4.95.
Coming back to Viking Therapeutics Inc (NASDAQ:VKTX), we note that the average 3-month trading volume was 6.41 million. Current shares outstanding are 109.36 million.
The insiders hold 8.08% of the company’s shares while institutions hold 69.02%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 299.30% up in year-to-date price movement.
